Navigation Links
NewLink Genetics Presents Positive Phase 2 Data on Novel Immunotherapy, Tergenpumatucel-L, in Non-Small Cell Lung Cancer at the ASCO 2013 Annual Meeting
Date:6/1/2013

AMES, Iowa, June 1, 2013 /PRNewswire/ -- NewLink Genetics Corporation (NASDAQ: NLNK), an oncology-focused biopharmaceutical company specializing in immunotherapy, today announced results from a Phase 2 clinical study with tergenpumatucel-L. The study evaluated the safety and activity of tergenpumatucel-L in 28 previously treated patients with metastatic or recurrent non-small cell lung cancer (NSCLC).  All patients in the study received tergenpumatucel-L as a single agent, which resulted in long term stable disease (>/= 16 weeks) in 8 of the 28 patients, including one patient who survived 50 months. Median overall survival of 11.3 months with tergenpumatucel-L as a single agent was also encouraging in this patient population. Sixteen of the patients whose disease progressed following tergenpumatucel-L therapy received salvage chemotherapy. The partial response rate was 31 percent (5/16) and an additional 25 percent (4/16) achieved stable disease, suggesting that tergenpumatucel-L enhanced the response rate of the salvage chemotherapy. The safety and tolerability of tergenpumatucel-L was demonstrated in the study with no serious drug related (grade 4) adverse events reported; the most frequent drug related adverse events reported in the study were skin reactions at the injection sites.

NewLink is currently conducting a Phase 2b/3 trial comparing tergenpumatucel-L to docetaxel for patients with previously treated NSCLC. This study will compare the response rates of follow-on chemotherapy for patients whose disease progresses in either the docetaxel or tergenpumatucel-L arm to further investigate tergenpumatucel-L's potential to produce a chemo-sensitization effect. Tergenpumatucel-L is the second most advanced product in clinical testing from NewLink's HyperAcute platform technology.

"Lung cancer continues to be the leading cause of
'/>"/>

SOURCE NewLink Genetics Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. NewLink Genetics to Present at the Needham and Company 12th Annual Healthcare Conference
2. NewLink Genetics Presents Preclinical Data on NLG919, a New Drug Candidate from a Novel Class of IDO Pathway Inhibitors for the Treatment of Cancer
3. NewLink Genetics Announces Timing of Fourth Quarter and Year-End 2012 Financial Results Conference Call
4. NewLink Genetics Corporation Announces Exercise of Underwriters Option and Closing of Public Offering of Common Stock
5. NewLink Genetics Corporation Announces Pricing of Public Offering of Common Stock
6. NewLink Genetics Corporation Announces Proposed Public Offering of Common Stock
7. Clinical Data from NewLink Genetics HyperAcute Prostate Cancer Immunotherapy Published in Journal of Immunotherapy
8. Lota S. Zoth joins NewLinks Board of Directors; heads Audit Committee
9. Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference
10. Millennium HealthCare Signs Distribution Agreement with Atossa Genetics
11. Metamark Genetics Board of Directors Appoints Shawn M. Marcell President and Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... , May 5, 2015  IQPC,s 19 th ... announce the chairman of the Summit Mr. Phani Bidarahalli ... will be joined by the expert speaker faculty including senior ... May 11 – 12, at The Hotel Kabuki in ... is available for download on the event website, which can ...
(Date:5/5/2015)...  Accuray Incorporated (Nasdaq: ARAY ), announced today that ... America Merrill Lynch 2015 Healthcare Conference in ... at 2:20pm PT.   A live webcast ... Relations page of the Company,s website at http://www.accuray.com/investors ... approximately one hour after the conclusion of the live ...
(Date:5/5/2015)... , May 5, 2015  Image Stream Medical, ... new agreement with MedAssets, one of the largest group ... the United States.  Under terms of the three-year agreement, ... and services will be made available to MedAssets members ... the partnership, Image Stream Medical CEO Eddie Mitchell ...
Breaking Medicine Technology:Phani Bidarahalli from Wipro to chair the upcoming 19th Software Design for Medical Devices Summit in San Francisco 2Image Stream Medical Announces Agreement with MedAssets 2
... (NYSE: PFE ) announced today it is ... myeloid leukemia (CML) based on data from a clinical ... treated patients.  These regulatory submissions are planned for 2011. ... has begun the process of preparing a Marketing Authorization ...
... 3, 2010 US Oncology, Inc ., the nation,s ... with US Oncology Research participated in studies that ... Hematology ( ASH ) Annual Meeting and Exposition at the ... other investigators in the US Oncology Research Network participated in ...
Cached Medicine Technology:Pfizer Plans Regulatory Submissions of Bosutinib in Chronic Myeloid Leukemia 2Pfizer Plans Regulatory Submissions of Bosutinib in Chronic Myeloid Leukemia 3Pfizer Plans Regulatory Submissions of Bosutinib in Chronic Myeloid Leukemia 4Pfizer Plans Regulatory Submissions of Bosutinib in Chronic Myeloid Leukemia 5US Oncology Research Investigators Participated in Studies That Will be Presented at the 2010 American Society of Hematology Annual Meeting and Exposition 2US Oncology Research Investigators Participated in Studies That Will be Presented at the 2010 American Society of Hematology Annual Meeting and Exposition 3US Oncology Research Investigators Participated in Studies That Will be Presented at the 2010 American Society of Hematology Annual Meeting and Exposition 4
(Date:5/5/2015)... The brains of people with type 1 ... slower information processing, according to research led by the ... . , The findings indicate that clinicians should ... cognitive difficulties. If progressive, these changes could influence their ... the National Institutes of Health (NIH), is ...
(Date:5/5/2015)... California (PRWEB) May 05, 2015 On ... Downtown Los Angeles, CA, Choices Recovery sponsored Durkin Entertainment’s ... Durkin, LA’s leading producer of sustainable product placement in ... of the world’s top providers of ecologically sound and ... a premier red carpet event that makes appearances at ...
(Date:5/5/2015)... What do you get when you combine ... greatest mountaineers and one of the world’s greatest causes? The ... documentary by Marc Middleton, which follows world-renowned mountaineer Chris Warner ... 19,341-foot frozen summit of Mount Kilimanjaro. , “This film ... to action. Viewers are moved to ask, ‘What can I ...
(Date:5/5/2015)... 05, 2015 Buckeye Health Plan (BHP) ... CEO and plan president of Buckeye Health Plan. Hill, ... position immediately. , Hill has more than 28 years ... Pacific Northwest, from managed care to large health care ... CEO of HealthPlus of Michigan, a health plan serving ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 ... leadership guidebook called “Medicare Breakeven Challenges? A ... guidebook includes:, ,     Formulas for ... aren’t measuring but should be , ... unproductive “white space” and ensures sustained efficient ...
Breaking Medicine News(10 mins):Health News:Accelerated Brain Aging in Type 1 Diabetes Related to Cognitive Complications 2Health News:Accelerated Brain Aging in Type 1 Diabetes Related to Cognitive Complications 3Health News:Accelerated Brain Aging in Type 1 Diabetes Related to Cognitive Complications 4Health News:Choices Recovery Mishawaka Talks About Overcoming Adversity with Actor Matthew Ziff at the “RockNRolla Movie Awards” EcoLuxe Lounge 2Health News:LIVESTRONG & Bolder Broadcasting Present Special Edition of Conquering Kilimanjaro 2Health News:LIVESTRONG & Bolder Broadcasting Present Special Edition of Conquering Kilimanjaro 3Health News:Buckeye Health Plan Announces New Chief Executive Officer 2Health News:Buckeye Health Plan Announces New Chief Executive Officer 3Health News:Care Logistics Publishes a New Hospital Guidebook for Achieving Medicare Breakeven 2
... , , , INDIANAPOLIS, ... District of Indiana today upheld Eli Lilly and Company,s (NYSE: ... tablets). In the case of Eli Lilly and Company ... favor of Lilly on all accounts for these method-of-use patents, ...
... , , SAN FRANCISCO, ... a leader in the development, manufacturing and sales of products ... disease, said today that the two-year results of the Fractional ... confirm the importance of FFR in improving patient outcomes and ...
... and communication can alleviate the psychological distress and burnout ... University of Rochester Medical Center researchers report in today,s ... Association ( JAMA ). The training also ... and enhance patient-centered care, according to the researchers, who ...
... , , , ... today that the organization,s mail-in pharmacy benefits ranked highest in ... National Pharmacy Study(SM). The study measured more than a ... across five factors: ordering convenience, delivery convenience, medication availability and ...
... building in Congress ... empowering small dollar ... Elections Now Coalition, which represents seven national campaign reform organizations, today praised Rep. Peter DeFazio ... cosponsoring the bipartisan Fair Elections Now Act, H.R. 1826. , , The ...
... , CHICAGO, Sept. 23 , , Study 1 highlights : ... blood pressure in men. , A drug used to treat gout seems to ... Study 2 highlights : , , A study ... blood pressure, weight gain and behavior. , , , ...
Cached Medicine News:Health News:U.S. District Court Upholds Validity of Lilly's Evista Patents Through 2014 2Health News:U.S. District Court Upholds Validity of Lilly's Evista Patents Through 2014 3Health News:Volcano Corporation Praises FAME Study Results 2Health News:Volcano Corporation Praises FAME Study Results 3Health News:Volcano Corporation Praises FAME Study Results 4Health News:Volcano Corporation Praises FAME Study Results 5Health News:Mindful meditation, shared dialogues reduce physician burnout 2Health News:Mindful meditation, shared dialogues reduce physician burnout 3Health News:Mindful meditation, shared dialogues reduce physician burnout 4Health News:Kaiser Permanente Recognized by J.D. Power and Associates as Highest in Customer Satisfaction Among Mail-Order Pharmacies 2Health News:Kaiser Permanente Recognized by J.D. Power and Associates as Highest in Customer Satisfaction Among Mail-Order Pharmacies 3Health News:American Heart Association Meeting Report: High-Sugar Diet Increases Men's Blood Pressure; Gout Drug Protective 2Health News:American Heart Association Meeting Report: High-Sugar Diet Increases Men's Blood Pressure; Gout Drug Protective 3Health News:American Heart Association Meeting Report: High-Sugar Diet Increases Men's Blood Pressure; Gout Drug Protective 4Health News:American Heart Association Meeting Report: High-Sugar Diet Increases Men's Blood Pressure; Gout Drug Protective 5Health News:American Heart Association Meeting Report: High-Sugar Diet Increases Men's Blood Pressure; Gout Drug Protective 6
The latex free, hydrophilic Self-Cath Plus is designed for single use, intermittent self-catheterization. The unique hydrophilic coating activates immediately upon exposure to water for fast, clean...
Used for temporary urine collection. The leg bag is designed for use with the Non-Adhesive Silicone Condom Catheter. Supplied non-sterile. Reusable. Intended for single patient use only....
The latex free, hydrophilic Self-Cath Plus is designed for single use, intermittent self-catheterization. The unique hydrophilic coating activates immediately upon exposure to water for fast, clean...
... The Self-Cath Closed System is ... a method for safe, simple catheterization ... urinary tract infections. It includes ... The new EasyOff tear tab ...
Medicine Products: